Lastly, our results highlight that after DNA damage, the downregulation of XRRA1 expression enhanced ATM activity to activate CHK1 and CHK2, thereby regulating radiotherapy sensitivity of CRC cells. This evidence concerns the gene CHEK2 and colorectal carcinoma.